![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Warns Two Breast Implant Makers Over Post-Approval Studies
FDA Warns Two Breast Implant Makers Over Post-Approval Studies
April 1, 2019
The FDA served two breast implant manufacturers with warning letters after the agency found they failed to comply with post-approval study requirements.
The FDA found that the two silicone gel-filled breast implant makers — Johnson & Johnson’s Mentor Worldwide of Irvine, California and Sientra of Santa Barbara, California — violated the requirement that they conduct post-approval studies to assess the long-term safety and risks of their implants.
The agency found both companies were in violation of two of the seven post-approval study requirements which were set as part of their 2013 premarket approval applications.
Upcoming Events
-
21Oct